Ovid Therapeutics Inc. OVID
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- +46.63%
- 1 year
- +71.94%
- Open
- 2.55
- Prev close
- 2.54
- Mkt cap
- 466.76M
- Vol
- 2.34M
- Avg vol
- 1.71M
- EPS
- -0.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.37
- High
- 2.60
- Forward P/E
- -2.44
- Beta
- 0.41
- Short ratio
- 3.05
- Inst. own
- 56.41%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.14
- 200-d avg
- 1.76
- 1y target
- 3.26
5D chart
Signals (72)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 1:15 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 12:15 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 12:15 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 11:30 AM | 19 hours ago |
| SMA: Bullish | Nov 2, 11:25 AM | 19 hours ago |
| RSI: Oversold | Nov 2, 11:15 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 11:05 AM | 20 hours ago |
| SMA: Bullish | Nov 2, 11:00 AM | 20 hours ago |
| RSI: Oversold | Nov 2, 10:15 AM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 10:00 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 9:45 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 9:45 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 9:35 AM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 9:30 AM | 21 hours ago |
| MACD: Sell Signal | Oct 30, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 3:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 3 days ago |
Newest 20 of 72.
News
-
2 weeks ago benzinga.com
Wolfe Research Initiates Coverage On Ovid Therapeutics with Outperform Rating, Announces Price Target of $5
Wolfe Research initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Outperform rating and announces Price Target of $5.
-
3 weeks ago benzinga.com
Cantor Fitzgerald Initiates Coverage On Ovid Therapeutics with Overweight Rating
Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Overweight rating.
-
4 weeks ago benzinga.com
Guggenheim Initiates Coverage On Ovid Therapeutics with Buy Rating, Announces Price Target of $7
Guggenheim analyst Delma Caiati initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Buy rating and announces Price Target of $7.
-
4 weeks ago benzinga.com
Guggenheim Initiates Coverage On Ovid Therapeutics with Buy Rating, Announces Price Target of $7
Guggenheim analyst Delma Caiati initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Buy rating and announces Price Target of $7.
1 month ago benzinga.com
Vail Resorts, Inventiva And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. futures mixed as Vail Resorts fell after a Q4 loss miss despite beating sales estimates; several stocks also declined premarket.
-
1 month ago benzinga.com
HC Wainwright & Co. Maintains Buy on Ovid Therapeutics, Raises Price Target to $5
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and raises the price target from $4 to $5.
-
2 months ago benzinga.com
Ovid Therapeutics Q2 EPS $(0.08) Beats $(0.12) Estimate, Sales $733.000K Beat $30.000K Estimate
Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 27.27 percent. This is a 33.33 percent decrease over losses of…
3 months ago benzinga.com
Rivian, Micron And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures mixed, Nasdaq 100 falls 200 pts. Rivian (RIVN) drops after public offering announcement. Other stocks also down in pre-market.
4 months ago benzinga.com
uniQure's Experimental Drug Shows Early Promise In Difficult-To-Treat Epilepsy
uniQure reported early seizure reductions in an AMT-260 epilepsy study, with no treatment-related serious adverse events.
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
7 months ago benzinga.com
Earnings Scheduled For March 18, 2026
Earnings Scheduled For March 18, 2026
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
11 months ago benzinga.com
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
3 years ago benzinga.com
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this…
-
3 years ago benzinga.com
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 838 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 149 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 198 companies reached new 52-week lows.
-
5 years ago benzinga.com
65 Biggest Movers From Friday
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares jumped 93.5% to close at $16.02 on Friday after the company late Thursday announced Sumitovant Biopharma will acquire the remaining stake in the…
-
5 years ago benzinga.com
54 Stocks Moving In Friday's Mid-Day Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares climbed 94% to $16.06 after the company late Thursday announced Sumitovant Biopharma will acquire the remaining stake in the company for $16.25 per…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 144 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 118 companies set new 52-week highs.
-
6 years ago benzinga.com
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
-
6 years ago benzinga.com
The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares
The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Monday
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019
Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 2nd
Stocks Which Set New 52-Week Low Yesterday, October 2nd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, September 25th
Stocks Which Set New 52-Week Low Yesterday, September 25th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, September 21st
Stocks Which Set New 52-Week Low Friday, September 21st
-
8 years ago benzinga.com
44 Stocks Moving In Monday's Mid-Day Session
44 Stocks Moving In Monday's Mid-Day Session